Anterix financials
$79.04−3.31%
Close Sep 29, 2026 · split-adjustedRevenue
Net income
Income statement & cash flow
| Fiscal year | FY26 Mar 31 | FY25 Mar 31 | FY24 Mar 31 | FY23 Mar 31 | FY22 Mar 31 | FY21 Mar 31 | FY20 Mar 31 |
|---|---|---|---|---|---|---|---|
| Revenue | $6.5M | $6.0M | $4.2M | $1.9M | $1.1M | $921.0K | $1.6M |
| Gross profit | $6.5M | $6.0M | $4.2M | $1.9M | $1.1M | -$685.0K | -$1.3M |
| Gross margin | 100.0% | 100.0% | 100.0% | 100.0% | 99.5% | −74.4% | −81.1% |
| Operating income | -$46.2M | -$52.8M | -$52.5M | -$54.9M | -$48.0M | -$50.9M | -$37.4M |
| Net income | $90.6M | -$11.4M | -$9.1M | -$16.3M | -$37.5M | -$54.4M | -$37.6M |
| Net margin | 1394.2% | −188.6% | −217.8% | −850.3% | −3461.2% | −5910.3% | −2406.5% |
| Diluted EPS | $4.83 | $-0.61 | $-0.49 | $-0.87 | $-2.07 | $-3.13 | $-2.29 |
| EBITDA | -$41.2M | -$48.5M | -$51.6M | -$53.4M | -$46.5M | -$47.3M | -$33.7M |
| Operating cash flow | $5.5M | -$29.3M | $42.0M | -$27.5M | $17.9M | -$30.0M | -$27.8M |
| Free cash flow | $5.5M | -$29.4M | $41.7M | -$29.6M | $16.9M | -$30.2M | -$28.3M |
| Diluted shares | 18.8M | 18.6M | 18.8M | 18.8M | 18.1M | 17.4M | 16.4M |
Balance sheet
| Period end | Mar 31 | Mar 31 | Mar 31 | Mar 31 | Mar 31 | Mar 31 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $98.5M | $47.4M | $60.6M | $43.2M | $105.6M | $117.5M |
| Short-term investments | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Total debt | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Total assets | $465.2M | $333.1M | $324.9M | $278.6M | $278.0M | $253.1M |
| Total liabilities | $202.9M | $176.5M | $163.9M | $98.8M | $91.7M | $40.5M |
| Shareholders' equity | $262.3M | $156.6M | $161.0M | $179.8M | $186.3M | $212.5M |
From SEC filings via Massive. Fiscal periods follow the company's own calendar; free cash flow is operating cash flow minus capital expenditure.
Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology